The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

Other AbbVie drugs, including its once-best-selling multiuse medication Humira, have been targeted by new provisions in the ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

The first generic version of Motegrity has been approved by the Food and Drug Administration and is now available.

Prucalopride was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic constipation, regardless of age, BMI or renal function, ...

Integrating physical exercise programs into a multidisciplinary care plan is highly recommended for the management of juvenile idiopathic arthritis-related chronic pain. Physical exercise ...

ANI is offering prucalopride tablets, which is the generic of Takeda's Motegrity. Motegrity is used in adults to treat chronic idiopathic constipation. "We are delighted to build momentum early in ...

Living with a chronic illness in the family is hard. It's even harder if you know that the person you love will get worse and won't recover from their condition. Sadly, it can happen to any family ...

Motegrity is a medication used to treat chronic idiopathic constipation (CIC) in adults. The FDA has granted Competitive Generic Therapy (CGT) designation to the company's Prucalopride ...

More information: Screening Patients for Physical Inactivity Helps Identify Patients at Risk for Cardiometabolic and Chronic Diseases, Preventing Chronic Disease (2024). Lucas J. Carr et al ...

The company' s lead investigational drug, plecanatide, is in late-stage clinical development for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation ...